Nabriva TherapeuticsNBRVF
13F holders, Q2 2024 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Nabriva Therapeutics PLC (NBRVF) in their 13F filings. The largest holder was Bay Harbor Wealth Management, LLC ($0).
- Company
- Nabriva Therapeutics PLC
- CUSIP
- G63637139
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Bay Harbor Wealth Management, LLC | 0.00% | New | 80 | $0 |
"% of holder's portfolio" is NBRVF's weight in each manager's 13F, not the share of Nabriva Therapeutics PLC the manager owns.